Delpomont Syrup 100 ml

Babies: Safe if prescribed. Consult your doctor.
Pregnancy: Studies have shown that there is a risk of adverse effects on the developing baby. Safe if prescribed.
Lactating mother: Studies have shown that montelukast can pass into breast milk and result in adverse effects on the baby. Your doctor will prescribe this medication based on the benefits to risk ratio.
Safe if prescribed. Alcohol: Use with caution.
It is not safe to consume alcohol while using delpomont syrup as it leads to excessive drowsiness. Consult your doctor.
Driving: It is unsafe to use while driving as it may affect your driving capabilities by causing drowsiness. Kidney: Used with caution.
Dose adjustment is needed in kidney abnormality patients. Safe if prescribed.
Liver: Use with caution. Dose adjustment is needed in liver abnormality patients.
Consult your doctor..

Dry mouth Rashes Headache Stomach pain Joint pain.

Delpomont is a leukotriene antagonist. It shows anti-inflammatory effects by blocking the release of a chemical messenger (leukotriene) and reduces the swelling of the airways.
Thus it helps in relieving allergic symptoms like breathlessness and makes it easy to breathe..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Delpomont is used in the treatment of allergic rhinitis, urticaria and mild to moderate asthma • Delpomont syrup is not for the treatment of instant asthma attacks. So always carry your inhalation device with you • Consult your doctor before stopping this medication • Tell your doctor if you use any other pain killers and allergy medications • It is preferably taken at evening time or as directed by your physician.

• Dasabuvir + Montelukast: Concurrent use of this medication may increase the concentration of dasabuvir • Gemfibrozil + Montelukast: Concurrent use of this medication may increase the montelukast concentration • Prednisone + Montelukast: Concurrent use of this medication may result in an increased risk of peripheral oedema • Propranolol + Montelukast: Concomitant use of this medication may decrease the propranolol concentration • Phenobarbital + Montelukast: Concurrent use of this medication may result in a decreased bioavailability of montelukast • Rifampin + Montelukast: Concurrent use of this medication may result in a decreased bioavailability of montelukast.